文中列出了食品和药物管理局（FDA）批准用于白血病的癌症药物。包括通用和品牌名称。还列出了白血病中常用的药物组合。组合中的各种药物经FDA批准。然而，药物组合本身通常不被批准，但被广泛使用。这些药物名称与NCI的“癌症药物信息”摘要相关。白血病中可能存在这些未列出的药物。
 


批准用于急性淋巴细胞性白血病（ALL）的药物：

Abitrexate (Methotrexate)                Arranon (Nelarabine)
Asparaginase Erwinia chrysanthemi        Blinatumomab
Blincyto (Blinatumomab)                 Cerubidine (Daunorubicin Hydrochloride)
Clafen (Cyclophosphamide)               Clofarabine
Clofarex (Clofarabine)                    Clolar (Clofarabine)
Cyclophosphamide                      Cytarabine
Cytosar-U (Cytarabine)                   Cytoxan (Cyclophosphamide)
Dasatinib                              Daunorubicin Hydrochloride
Doxorubicin Hydrochloride                Erwinaze (Asparaginase Erwinia Chrysanthemi)
Folex (Methotrexate)                    Folex PFS (Methotrexate)
Gleevec (Imatinib Mesylate)               Iclusig (Ponatinib Hydrochloride)
Imatinib Mesylate                       Marqibo (Vincristine Sulfate Liposome)
Mercaptopurine                        Methotrexate
Methotrexate LPF (Methorexate)           Mexate (Methotrexate)
Mexate-AQ (Methotrexate)                Nelarabine
Neosar (Cyclophosphamide)               Oncaspar (Pegaspargase)
Pegaspargase                           Ponatinib Hydrochloride
Prednisone                             Purinethol (Mercaptopurine)
Purixan (Mercaptopurine)                 Rubidomycin (Daunorubicin Hydrochloride)
Sprycel (Dasatinib)                       Tarabine PFS (Cytarabine)
Vincasar PFS (Vincristine Sulfate)            Vincristine Sulfate
Vincristine Sulfate Liposome
 
用于急性淋巴细胞性白血病（ALL）的药物组合：
 
Hyper-CVAD
 
药物批准用于急性骨髓性白血病（AML）：
 
Arsenic Trioxide                        Cerubidine (Daunorubicin Hydrochloride)
Clafen (Cyclophosphamide)               Cyclophosphamide
Cytarabine                            Cytosar-U (Cytarabine)
Cytoxan (Cyclophosphamide)             Daunorubicin Hydrochloride
Doxorubicin Hydrochloride               Enasidenib Mesylate
Idamycin (Idarubicin Hydrochloride)       Idarubicin Hydrochloride
Idhifa (Enasidenib Mesylate)              Midostaurin
Mitoxantrone Hydrochloride              Neosar (Cyclophosphamide)
Rubidomycin (Daunorubicin Hydrochloride)         Rydapt (Midostaurin)
Tabloid (Thioguanine)                  Tarabine PFS (Cytarabine)
Thioguanine                          Trisenox (Arsenic Trioxide)
Vincasar PFS (Vincristine Sulfate)         Vincristine Sulfate
 
用于急性骨髓性白血病（AML）的药物组合：
 
ADE
 
批准用于慢性淋巴细胞性白血病（CLL）的药物：
 
Alemtuzumab                       Ambochlorin (Chlorambucil)
Amboclorin (Chlorambucil)             Arzerra (Ofatumumab)
Bendamustine Hydrochloride           Campath (Alemtuzumab)
Chlorambucil                        Clafen (Cyclophosphamide)
Cyclophosphamide                   Cytoxan (Cyclophosphamide)
Fludara (Fludarabine Phosphate)        Fludarabine Phosphate
Gazyva (Obinutuzumab)               Ibrutinib
Idelalisib                           Imbruvica (Ibrutinib)
Leukeran (Chlorambucil)               Linfolizin (Chlorambucil)
Mechlorethamine Hydrochloride        Mustargen (Mechlorethamine Hydrochloride)
Neosar (Cyclophosphamide)            Obinutuzumab
Ofatumumab                        Prednisone
Rituxan (Rituximab)                   Rituximab
Treanda (Bendamustine Hydrochloride)   Venclexta (Venetoclax)
Venetoclax
Zydelig (Idelalisib)
 
用于慢性淋巴细胞性白血病（CLL）的药物组合：
 
CHLORAMBUCIL-PREDNISONE
CVP
 
批准用于慢性骨髓性白血病（CML）的药物：
 
Bosulif (Bosutinib)                    Bosutinib
Busulfan                            Busulfex (Busulfan)
Clafen (Cyclophosphamide)             Cyclophosphamide
Cytarabine                          Cytosar-U (Cytarabine)
Cytoxan (Cyclophosphamide)           Dasatinib
Gleevec (Imatinib Mesylate)            Hydrea (Hydroxyurea)
Hydroxyurea                         Iclusig (Ponatinib Hydrochloride)
Imatinib Mesylate                    Mechlorethamine Hydrochloride
Mustargen (Mechlorethamine Hydrochloride)     Myleran (Busulfan)
Neosar (Cyclophosphamide)            Nilotinib
Omacetaxine Mepesuccinate           Ponatinib Hydrochloride
Sprycel (Dasatinib)                    Synribo (Omacetaxine Mepesuccinate)
Tarabine PFS (Cytarabine)              Tasigna (Nilotinib)
 
批准用于毛细胞白血病的药物：
 
Cladribine
Intron A (Recombinant Interferon Alfa-2b)
Leustatin (Cladribine)
Recombinant Interferon Alfa-2b
 
药物批准用于肥大细胞白血病：
 
Midostaurin
Rydapt (Midostaurin)
 
药物批准用于脑膜炎白血病：
 
Cytarabine
Cytosar-U (Cytarabine)
Tarabine PFS (Cytarabine)

厚朴方舟2012年进入海外医疗领域，总部位于北京，建立了由全球权威医学专家组成的美日名医集团，初个拥有日本政府官方颁发的海外医疗资格的企业。如果您有海外就医的需要，请拨打免费热线400-086-8008进行咨询！

本文由厚朴方舟编译，版权归厚朴方舟所有，转载或引用本网版权所有之内容须注明"转自厚朴方舟官网（www.hopenoah.com）"字样，对不遵守本声明或其他违法、恶意使用本网内容者，本网保留追究其法律责任的权利。

上一篇：美国治疗于急性骨髓性白血病-美沙酮经FDA批准用于急性骨髓性白血病 下一篇：美国肝癌治疗药-美国近10年来 肝癌药物获FDA批准